2Ferrara N,Hillan KJ,Novotny W.Bevacizumab (Avastin),a humanized anti-VEGF monoclonal antibody for cancer therapy[J].Biochem Biophys Res Commun,2005,333 (2):328.
3Ferrara N.Vascular endothelial growth factor as a target for anticancer therapy[J].Oncologist,2004,9 (Sullp 1):2.
4Gordon MS,Margolin K,Talpaz M,et al.Phase Ⅰ safety and pharmacokinetic study of recombinant human anti-Vascular Endothelial Growth Factor in patients with advanced cancer[J].Journal of Clinical Oncology,2001,3 (19):843.
5Kabbinavar F,Hurwitz HJ,Fehrenbacher L,et al.Phase Ⅱ,randomized trial comparing bevacizumab plus fluororacil (FU)/leucovorin(LV)with FU/LV alone in patients with metastatic colorectal cancer[J].J Clin Oncol,2003,21 (1):60.
6Hurwitz H,Fehrenbacher L,Novotny W,et al.Bevacizumab plus irinotecan,fluorouracil,and leucovorin for metastatic colorectal cancer[J].N Engl J Med,2004,350(23):2335.
7Johnson DH,Fehrenbacher L,Novotny W,et al.Randomized Phase Ⅱ trial comparing Bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer[J].J Clin Oncol,2004,22(11):2184.
8Yang JC,Haworth L,Sherry RM,et al.A randomized trial of Bevacizumab,an anti -Vascular Endothelial Growth Factor antibody for metastatic renal cancer[J].N Engl J Med,2003,349(5):427.
9Rini BI,Halabi S,Taylor J,et al.Cancer and Leukemia Group B 90206:A randomized phase Ⅲ trial of interferonalpha or interferonalpha plus anti-Vascular Endothelial Growth Factor (bevacizumab) in metastatic renal cell carcinoma[J].Clin Cancer Res,2004,10 (8):2584.
10Cobleigh MA,Langmuir VK,Sledge GW,et al.A phase Ⅰ/Ⅱ dose-escalation trial of bevacizumab in previously treated metastatic breast cancer[J].Semin Oncol,2003,5 (Suppl 16):117.
9Therasse P, Arbuck SG, Eisenhauer EA et al. New guidelines to evaluate the response to treatment in solide tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada [ J ]. J Natl Cancer Inst,2000 ,92 :205
10Goldberg RM, Sargent DJ, Morton RF et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinationgs inpatients with previously untreated metastatic colorectal cancer[ J]. J Clin Oncol, 2004,22 : 23
